๊ธ‰์„ฑ ์‹ฌ๋ถ€์ „ / Acute heart failure

์ •์˜

๊ธ‰์„ฑ ์‹ฌ๋ถ€์ „์€ ์‹ฌ์žฅ ๊ธฐ๋Šฅ ์ €ํ•˜๋กœ ํ˜ธํก๊ณค๋ž€, ์šธํ˜ˆ, ์ฒด์•ก ์ €๋ฅ˜๊ฐ€ ๋‚˜ํƒ€๋‚˜๋Š” ์‘๊ธ‰ ์‹ฌํ˜ˆ๊ด€ ์ƒํƒœ๋กœ ์ •๋ฆฌ๋˜์–ด ์žˆ๋‹ค.

์ž„์ƒ ํ•ต์‹ฌ

์ˆ˜์ถ•๊ธฐ ์‹ฌ๋ถ€์ „์€ EF <50%, ์ด์™„๊ธฐ ์‹ฌ๋ถ€์ „์€ EF๊ฐ€ ์œ ์ง€๋˜๋Š” ํ˜•ํƒœ๋กœ ๊ตฌ๋ถ„๋˜์–ด ์žˆ๋‹ค. ์ฆ์ƒ์œผ๋กœ dyspnea on exertion, orthopnea, edema๊ฐ€ ์ œ์‹œ๋˜์–ด ์žˆ๋‹ค. CO ๊ฐ์†Œ โ†’ venous retention โ†’ congestive hepatopathy๋กœ AST/ALT ์ƒ์Šน, dilated IVC/hepatic veins, RUQ pain์ด ๊ฐ€๋Šฅํ•˜๋‹ค๊ณ  ์ •๋ฆฌ๋˜์–ด ์žˆ๋‹ค.

์ง„๋‹จ

Pro-BNP ์ƒ์Šน์ด ์–ธ๊ธ‰๋˜์–ด ์žˆ๋‹ค. BUN ์ƒ์Šน์€ 30์ผ ์ด๋‚ด ์‹ฌ๊ฐํ•œ ์ด์ƒ ๊ฒฐ๊ณผ ์˜ˆ์ธก์ธ์ž๋กœ ์ œ์‹œ๋˜์–ด ์žˆ๋‹ค. ์˜์ƒ/์ž„์ƒ์ ์œผ๋กœ pulmonary edema, pleural effusion, cardiomegaly ๋“ฑ์„ ์น˜๋ฃŒ ๊ฒฐ์ •์— ์ฐธ๊ณ ํ•œ๋‹ค.

์น˜๋ฃŒ

๊ธฐ๋ณธ ์น˜๋ฃŒ๋Š” Lasix(furosemide)๋กœ ์ •๋ฆฌ๋˜์–ด ์žˆ๋‹ค. Hypertensive HF(BP >150)์—์„œ๋Š” sublingual nitroglycerin์œผ๋กœ afterload ๊ฐ์†Œ, Lasix๋กœ volume overload ๊ฐ์†Œ๊ฐ€ ์ œ์‹œ๋˜์–ด ์žˆ๋‹ค. Pulmonary wheezing ๋™๋ฐ˜ ์‹œ nebulizer(SABA)๊ฐ€ ๋„์›€๋  ์ˆ˜ ์žˆ๋‹ค๊ณ  ์ •๋ฆฌ๋˜์–ด ์žˆ๋‹ค. Normotensive HF๋Š” Lasix๊ฐ€ ์ œ์‹œ๋˜์–ด ์žˆ๋‹ค.

์ถœ์ฒ˜

๐ŸŒฑ ์ถœ์ฒ˜ raw


๋ณธ ๋ฌธ์„œ๋Š” ํ•™์Šตยท์ฐธ๊ณ ์šฉ์ด๋ฉฐ ์‹ค์ œ ์ง„๋ฃŒ ๊ฒฐ์ •์€ ์ž„์ƒ์˜์˜ ํŒ๋‹จ์ž…๋‹ˆ๋‹ค.